Search
for
Sort by
Research 31–60 of 579
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- JAK inhibitors in dermatology: The promise of a new drug class
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- JAK Inhibitors for Treatment of Alopecia Areata
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Emerging treatments in alopecia
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- STAT5 Activation in the Dermal Papilla Is Important for Hair Follicle Growth Phase Induction
- A novel therapeutic paradigm for patients with extensive alopecia areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- New drugs under investigation for the treatment of alopecias
- Treating Alopecia Areata: Current Practices Versus New Directions
- Alopecia Areata: An Update on Treatment Options for Children
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Alopecia areata – Current understanding and management
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata